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Abstract
Background: Based on its activities in vitro, the mammalian mitochondrial transcription termination factor mTERF
has been proposed to regulate mitochondrial transcription by favouring termination at its high-affinity binding
immediately downstream of the rDNA segment of mitochondrial DNA, and initiation selectively at the PH1 site of
the heavy-strand promoter. This defines an rDNA transcription unit distinct from the ‘global’ heavy-strand
transcription unit initiating at PH2. However, evidence that the relative activities of the two heavy-strand
transcription units are modulated by mTERF in vivo is thus far lacking.
Results: To test this hypothesis, we engineered human HEK293-derived cells for over-expression or knockdown of
mTERF, and measured the steady-state levels of transcripts belonging to different transcription units, namely
tRNALeu(UUR) and ND1 mRNA for the PH2 transcription unit, and tRNAPhe plus 12S and 16S rRNA for the PH1
transcription unit. The relative levels of 16S rRNA and ND1 mRNA were the same under all conditions tested,
although mTERF knockdown resulted in increased levels of transcripts of 12S rRNA. The amount of tRNAPhe relative
to tRNALeu(UUR) was unaffected by mTERF over-expression, altered only slightly by mTERF knockdown, and was
unchanged during recovery from ethidium bromide-induced depletion of mitochondrial RNA. mTERF
overexpression or knockdown produced a substantial shift (3-5-fold) in the relative abundance of antisense
transcripts either side of its high-affinity binding site.
Conclusions: mTERF protein levels materially affect the amount of readthrough transcription on the antisense
strand of mtDNA, whilst the effects on sense-strand transcripts are complex, and suggest the influence of
compensatory mechanisms.
Background
Mammalian mitochondrial DNA is organized into three
multicistronic transcription units (reviewed in [1], Fig.
1A), which give rise to the mature RNAs encoded by
the circular genome: two ribosomal RNAs, 22 tRNAs
and 11 mRNAs (2 of them bicistronic). Each strand is
transcribed in its entirety, employing closely spaced pro-
moters located within the major non-coding region of
the genome, namely LSP, the promoter of the light-
strand, with a unique initiation site designated PL, and
PH1 and PH2, the alternate transcription start sites of
the heavy-strand promoter (HSP), which give rise to
partially overlapping transcripts. Based on metabolic
labeling studies, PH1 and PH2 have been inferred to
give rise to distinct primary transcripts of the heavy-
strand [2]. PH1 is located within the non-coding region
and generates a primary transcript comprising both
rRNAs and two tRNAs (-Phe and -Val), terminating at
the end of the rDNA region, mainly within the 5’ end of
the tRNALeu(UUR) gene [3]. PH2 is located within the
coding sequence of tRNAPhe and generates a primary
transcript comprising all of the remaining heavy-strand
encoded genes. PL generates a primary transcript com-
prising the entire light strand.
The mechanism by which the transcriptional machin-
ery selects between these different initiation sites, and
also effects selective termination at the end of the
rDNA, in the case of transcripts initiated at PH1, is
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incompletely understood. It can be manipulated in orga-
nello by various drugs and by ATP [4-6]. The mitochon-
drial RNA polymerase comprises a single catalytic
subunit, MTRPOL, plus an accessory factor, TFB2M,
required for formation of the initiation complex in vitro
at both HSP and LSP [7,8], together with mitochondrial
transcription factor A (TFAM), which is needed for pro-
moter-dependent transcription in vitro [7,9]. TFAM has
a natural binding affinity for DNA and has been sug-
gested also to play a more general role in organizing the
mitochondrial chromosome, analogous with bacterial
HU or eukaryotic and archaeal histones. A third factor,
mTERF, with sequence-specific binding affinity for a
sequence located within the tRNALeu(UUR) gene immedi-
ately downstream of the rDNA [10,11], has been pro-
posed to play a key role in both initiation and
termination of the PH1 transcription unit [12].
mTERF has selective termination activity in vitro on
templates containing its high-affinity binding site in the
tRNALeu(UUR) gene [10,13]. In crude extracts [14], as
well as in a reconstituted system based on recombinant
proteins [15], this activity appears to be bidirectional,
but operates in the latter case more efficiently in the
reverse direction, i.e. to terminate transcription initiating
from the LSP side more efficiently than from HSP [15].
Based on the fact that it has weak binding to other sites
Figure 1 Manipulation of mTERF expression has minimal effects on steady-state levels of mature mitochondrial RNAs. (A) Schematic
diagram of the promoter and rDNA region of human mtDNA. Because mTERF binding dictates the use of alternate transcriptional start sites and
terminators, tRNAPhe and tRNALeu(UUR) fall into separate transcription units (PH1 and PH2 respectively). (B) Relative expression of mitochondrial
transcripts in cells overexpressing mTERF, based on phosphorimaging of Northern blots probed successively for mitochondrial tRNAPhe and
tRNALeu(UUR) and for 5S rRNA. Data (means ± SD) are signal ratios of tRNAPhe to tRNALeu(UUR) (F/L) and tRNAPhe to 5S rRNA (F/5S) for the mTERF-
overexpressing clones shown in Additional File 1, Fig. S1, normalized to the corresponding ratio in cells stably transfected with empty-vector.
Bars shown alongside are based on single reference experiments, using HEK293T cells transiently transfected with the same construct, or mock-
transfected. (C) Q-RT-PCR analysis (means ± SD) of mitochondrial transcript levels, plus cytosolic18S rRNA, as indicated, in Flp-In™ T-Rex™-293 cells
over-expressing mTERF-MycHis after doxycyclin induction for 3 d (or not induced). Data were normalized, in each case, to the corresponding
ratio for uninduced cells. (D) Relative expression of mitochondrial transcripts in cells knocked down for mTERF, as indicated. – denotes mock-
transfection. Northern blot probed successively for 16S rRNA and ND1 mRNA, as shown. The panels represent non-adjacent pairs of lanes from
the same exposure of the same gel. (E) Relative expression of mitochondrial transcripts in cells knocked down for mTERF, as indicated, calculated
from Northern blot data as in (B), normalized to the corresponding ratio in mock-transfected HEK293T cells. * indicates significant differences
from the corresponding mock-transfected cells, and # a significant difference between cell-lines (t-test, p values as in text). For original blots see
Additional File 1, Fig. S1C. Note that additional Q-RT-PCR data on levels of 12S rRNA gene transcripts are shown in Fig. 3.
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in mtDNA, including the promoter region [12,16,17], it
has been proposed that mTERF favours transcription of
the PH1 transcription unit by simultaneous binding to
the promoter and to the terminator region, creating a
loop structure that can be visualized in vitro [12]. The
level of active mTERF would thus act as a fine tuning of
the relative production of rRNA and mRNA.
There are, however, some problems associated with
this model. First, efficient transcription from PH1 in
vitro does not require mTERF (although does appear to
be stimulated by it [18]), whereas transcription from
PH2 in vitro is weak [18]. Second, measurements of the
relative half-lives of mitochondrial rRNAs and mRNAs
in cultured cells [19] indicate that post-transcriptional
regulation is substantial and may in fact be sufficient to
maintain the different transcript levels seen in vivo,
without the need for any differential regulation of tran-
scription from the PH1 and PH2 transcription units.
Note that, although the synthesis rates of mitochondrial
rRNAs and mRNAs appear to be very different in both
cultured cells [19] and rat liver [20], ‘synthesis rate’ here
includes RNA processing as well as transcription. In
organello, the combined rate of accumulation of pre-
rRNA plus mature rRNA is, in fact, lower than that of
mRNA [6]. Third, no modulation of transcription from
the two initiation sites correlating with mTERF activity
has ever been convincingly demonstrated in vivo.
Fourth, in cells bearing the 3423A > G mutation, which
greatly impairs mTERF binding in vitro, there is no
alteration in the relative levels of 16S rRNA and ND1
mRNA [21,22], and no alteration in site occupancy in
vivo, based on footprinting studies [21]. Fifth, decreased
levels of mTERF expression in Mpv17 knockout mice
are associated with globally increased mitochondrial
transcription [23], suggesting rather than mTERF may
function in vivo as a negative but general regulator of
transcription. Finally, whilst recombinant mTERF is
active in a reconstituted system in vitro [15], its activity
in the presence of less pure mitochondrial extracts is
subject to post-translational modifications and/or the
presence of other proteins [11-13,18,24], raising doubts
as to whether and how it influences transcription in
vivo.
mTERF is a member of a family of organellar proteins
proposed to interact with DNA to produce a variety of
outcomes [25]. In mammals, two homologues of
mTERF, MTERFD1 (mTERF3) and MTERD3
(mTERF2), have been shown to influence mitochondrial
RNA levels and have been proposed to act as regulators
of transcription from LSP [26,27], with consequent
effects on oxidative phosphorylation mediated brought
about by altered translation, as seen also in Drosophila
[28]. However, neither mTERF homologue has been
conclusively demonstrated to have high-affinity
sequence-specific binding to DNA [26,27,29]. Homolo-
gues of mTERF in invertebrates have been demonstrated
to influence both RNA and DNA synthesis in vitro, but
here too, there is only weak evidence for a specific role
in vivo. The mTERF-homologue in sea urchins, mtDBP,
binds to at least two sites in the mitochondrial genome
[30] and exhibits bidirectional transcription termination
activity in vitro in the presence of human mitochondrial
RNA polymerase, although it acts unidirectionally in
combination with phage polymerases [31]. It also
impedes the progress of DNA polymerase bidirection-
ally, acting as a contrahelicase in vitro [32], suggesting a
possible role in DNA replication. A role for mTERF in
mammalian mtDNA replication is also suggested by the
observation that the level of mTERF expression in cul-
tured human cells influences replication pausing in the
vicinity of mTERF binding sites [16]. The Drosophila
mTERF homologue mTTF binds to two putative tran-
scriptional terminators [33], acting in vitro with similar
directional properties to mtDBP [34]. Manipulation of
DmTTF levels in cultured cells leads to effects on tran-
script levels consistent with it acting in the manner
hypothesized for mTERF, i.e. as a regulator of termina-
tion (bidirectionally) and also of promoter activity [35].
The difficulty of interpreting in vitro experiments, and
the open questions regarding the role of mTERF in vivo,
prompted us to address the issue of whether and how
mTERF activity influences mitochondrial RNA levels in
cultured human cells. Clearly, if mTERF is a regulator
of mitochondrial transcription in vivo, via a model as
proposed, up- or down-regulation of its expression
should influence mitochondrial RNA levels in a predict-
able fashion. We therefore undertook a study of mito-
chondrial transcripts in cells over-expressing or knocked
down for mTERF. Surprisingly, we found that varying
the level of mTERF over a wide range has only a small
effect on the levels of sense-strand transcripts of the
mitochondrial genome in the rDNA region. Conversely,
we detected a clear effect on the relative amounts of
antisense transcripts on the two sides of the high-affinity
binding site. These findings support a role for mTERF
in influencing mitochondrial transcription in vivo, but
not in setting the levels of mature mitochondrial
transcripts.
Results
Over-expression of mTERF does not alter steady-state
levels of mature mitochondrial RNAs
To evaluate whether the expression level of mTERF
influences the steady-state levels of the mature mito-
chondrial transcripts encoded on either side of its high-
affinity binding site, we generated a series of transfected
HEK293T cell clones stably over-expressing the natural
mTERF protein. Expression of the mTERF transgene
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was verified at the RNA level by Q-RT-PCR (Additional
File 1, Fig. S1A) and at the protein level by the substan-
tial increase in DNA-binding capacity at the high-affinity
mTERF binding site, as judged by EMSA (electrophore-
tic mobility shift assay, Additional File 1, Fig. S1B).
We analysed two parameters which we considered
diagnostic for the relative utilization of the two heavy-
strand transcription units predicted by the classic model
of mammalian mtDNA transcription (Fig. 1A). The first
is the relative amounts of tRNAs -Phe and -Leu(UUR),
which are exclusively produced by transcription from
PH1 and PH2, respectively, according to the classical
model. The second is the relative amounts of mature
16S rRNA and ND1 mRNA. The latter is synthesized
via transcription from PH2, whereas the former has
been proposed to be generated mainly or exclusively
from transcription initiating at PH1, although it has not
been formally excluded that transcription from PH2 also
contributes some of the 16S rRNA. We found that the
relative amounts of tRNAs -Phe and -Leu(UUR) in dif-
ferent cell-clones over-expressing natural mTERF was
indistinguishable from that in control cells transfected
with empty vector (Fig. 1B), and was also unchanged in
cells transiently transfected with the mTERF overexpres-
sion construct (or mock transfected cells). The global
amount of mitochondrial transcription, as measured by
the ratio of tRNAPhe to cytosolic 5S rRNA was more
variable, but showed no systematic relation to mTERF
overexpression (Fig. 1B). We also found no detectable
alteration in the relative amounts of mature NDI1
mRNA and 16S rRNA between mTERF over-expressing
clones and control cells, based on Northern blots (Fig.
1D: compare lanes 1 of panels i and ii [control cells]
with lanes 1 of panels iii and iv [over-expressing cells]).
In an effort to quantify any such effect and avoid possi-
ble influences of cell background, we also used Q-RT-
PCR to analyse transcripts of the 16S and ND1 genes in
RNA extracted from Flp-In™ T-Rex™-293 cells stably
transfected with the mTERF-MycHis construct, in which
expression of mTERF can be induced by doxycycline
(Fig. 1C). We found no differences in the relative
amounts of transcripts from these two genes, nor in the
ratio of either to cytosolic 18S rRNA transcripts.
Effects of mTERF knockdown on steady-state levels of
mature mitochondrial RNAs
In previous studies [16] we noted that transfection with
an siRNA directed against mTERF suppressed most of
the binding activity at the high-affinity mTERF binding
site, as judged by EMSA [16]. We therefore compared
the relative levels of mitochondrial transcripts in cells
knocked down for mTERF. Northern blots probed suc-
cessively for 16S rRNA and ND1 mRNA showed no dif-
ference in the relative levels of these mature transcripts
in HEK293T cells after prolonged treatment (7 d) with
an mTERF-specific siRNA (Fig. 1D: compare lanes 1
and 2 of panels i and ii), nor in mTERF-MycHis over-
expressing cells knocked down for mTERF (Fig. 1D:
compares lanes 1 and 2 of panels iii and iv). mTERF
knockdown in HEK293T cells did, however, produce a
small but significant decrease in the relative amount of
tRNAPhe compared with tRNALeu(UUR), (Fig. 1E, t-test, p
< 0.05), accompanied by an increase in the overall
amount of mitochondrial tRNAs, represented by the
ratio of mitochondrial tRNAPhe to cytosolic 5S rRNA (t-
test, p < 0.01). siRNA treatment of mTERF-MycHis
overexpressing cells caused no significant alteration in
mitochondrial tRNAs (Fig. 1E), compared with mock-
transfected cells. Note also that cells overexpressing
mTERF-MycHis showed no clear difference from
HEK293T cells in the relative levels of mitochondrial
tRNAPhe and tRNALeu(UUR) (Fig. 1E), although mito-
chondrial tRNA levels globally were lower than in
untransfected HEK293T cells (t-test, p < 0.01).
Manipulation of mTERF expression does not alter the
relative levels of mitochondrial tRNAs during recovery
from mitochondrial RNA depletion
Reasoning that the steady-state levels of mature mito-
chondrial transcripts may not accurately reflect their
transcription rates in vivo, due to the influence of post-
transcriptional processing, we set out to study whether
the level of mTERF expression can influence the re-
accumulation of tRNA transcripts belonging to the PH1
and PH2 transcription units during recovery from ethi-
dium bromide (EtBr)-induced depletion of mitochon-
drial RNA. We compared the ratio of mitochondrial
tRNAs -Phe and -Leu(UUR) in stably transfected cells
overexpressing mTERF-with that in empty vector-trans-
fected cells over 2 days of EtBr treatment followed by 5
days of recovery (Fig. 2A, Additional File 1, Fig. S2A). In
both cell lines the ratio fell substantially during deple-
tion, reflecting the much shorter half-life of tRNAPhe,
but then recovered to levels higher than those seen in
untreated cells, before decreasing again gradually,
towards the starting value. This may indicate that the
PH2 transcription unit is used preferentially during
recovery from depletion. However, this did not appear
to be influenced by the level of mTERF, since the same
pattern was seen in control cells and in three separately
analysed overexpressor cell lines, as well as in cells
knocked down for mTERF by treatment with the
mTERF-specific siRNA, which behaved indistinguishably
from mock-transfected cells (Fig. 2B). The overall
kinetics of recovery of mitochondrial transcripts com-
pared with cytosolic 5S rRNA was also similar, compar-
ing cells over-expressing mTERF with control cells
(Additional File 1, Fig. S2B), and comparing cells
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knocked down by mTERF-specific siRNA with mock-
transfected cells (Additional File 1, Fig. S2C).
Manipulation of mTERF expression influences both sense-
and antisense-strand transcription
Since the effects of manipulating mTERF expression
on the levels of mature 16S rRNA and ND1 mRNA
did not reveal any significant changes, we used strand-
specific quantitative RT-PCR to analyse effects on the
levels of both sense-strand and antisense-strand tran-
scripts derived from specific regions of these genes
either side of the high-affinity mTERF binding site. We
analyzed the relative levels of antisense transcripts
from portions of the ND1 and 16S genes in three con-
texts in which mTERF expression was manipulated
(Fig. 3B). In cell clones stably overexpressing mTERF
the relative level of anti-16S to anti-ND1 RNA was
decreased compared to control cells transfected with
the empty vector, although this difference was only
statistically significant in one of the two clones studied.
Induction of mTERF expression in Flp-In™ T-Rex™-293
cells stably transfected with the mTERF construct also
resulted in a substantial and statistically robust
decrease in the anti-16S:anti-ND1 ratio, whereas trans-
fection of HEK293T cells with an shRNA targeted on
mTERF resulted in the opposite effect, i.e., a significant
Figure 2 Manipulation of mTERF expression has minimal effects on levels of mature mitochondrial RNAs during recovery from EtBr-
induced depletion. Relative expression of mitochondrial transcripts in cells overexpressing mTERF, based on phosphorimaging of Northern
blots probed successively for mitochondrial tRNAPhe and tRNALeu(UUR). Data (means ± SD) are ratios of tRNAPhe to tRNALeu(UUR) (F/L) normalized
to the ratio at the start of the experiment (time-point –2 d). (A) Cells stably transfected with empty-vector (as shown in Additional File 1, Fig.
S1B) or mTERF overexpression (OE) construct (clone 3, as shown in Additional File 1, Fig. S1). Overexpressor clones 1 and 2 gave similar results:
sample blots shown in Additional File 1, Fig. S2A. (B) Cells treated with mTERF-specific siRNA (or mock-transfected) prior to the addition of EtBr
(day –2) and again 2 days after removal of EtBr (day 2). Days 1-5 indicate the period of subsequent recovery. For equivalent data on ratio of
tRNAPhe to 5S rRNA from the same experiment see Additional File 1, Fig. S2B, C.
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large increase in the relative amount of anti-16S RNA.
Notably, the pattern of changes in each RNA differed
in the two cases (over-expression and knockdown),
when comparing its level in treated versus untreated
cells (Fig. 3C, D). Induced overexpression, which
resulted in a 20-fold increase in mTERF mRNA (Fig.
3E), produced a severe decrease in antisense tran-
scripts from the 16S gene, but also a small decrease in
the level of anti-ND1 (Fig. 3C). mTERF knockdown
(by a factor of 2 at the RNA level: Fig. 3F) produced
no significant effect on antisense transcripts of 16S,
but a sharp drop in the level of anti-ND1 (Fig. 3D).
We validated the main findings using a second primer
set (Additional File 1, Fig. S3B), which was also used to
test effects on the relative amounts of sense-strand tran-
scripts from the 16S and ND1 genes, which were found
to be unaffected by these manipulations, as expected
from the analysis of mature transcripts by Northern
blots (Fig. 1). In addition, we analysed effects on sense-
strand transcript from the 12S rRNA gene, and
Figure 3 Manipulation of mTERF expression affects relative levels of antisense transcripts of the 16S rRNA and ND1 genes. (A)
Schematic diagram of 16S rDNA-ND1 region of human mtDNA. For full details of primer sequences and location, see Additional File 1, Table S1.
(B) Relative steady-state levels of anti-16S and anti-ND1 transcripts, determined by Q-RT-PCR using proximity probe hybridization (probe sets R1,
N1 and C1 for normalization), after various manipulations of mTERF expression, i.e. two mTERF overexpressor clones (OE) compared with vector-
transfected cells, doxycyclin-induced versus uninduced Flp-In™ T-Rex™-293 cells transfected with mTERF expression construct, and HEK293T cells
transfected with mTERF-targeted shRNA versus mock-transfected cells. In each case, data were normalized to the corresponding control cells.
* denotes statistically significant differences from control cells (t test, p < 0.02). (C, D) Relative changes in anti-16S and anti-ND1 transcripts, based
on replotting of data from the experiment of panel B for each transcript individually, (C) following induced expression of mTERF in Flp-In™ T-
Rex™-293 cells and (D) in HEK293T cells transfected with mTERF-targeted shRNA versus mock-transfected cells. Data were normalized to values
for corresponding untreated control cells, using 18S as internal normalization standard. * denotes statistically significant differences from
corresponding control cells (t test, p < 0.01). (E, F) Relative steady-state levels of 12S, 16S and 18S sense-strand transcripts, as determined by
Q-RT-PCR using of proximity probe hybridization (primer sets T1, R2, C1 respectively, as described in Additional File 1, Table S1), and of mTERF
mRNA relative to 18S rRNA (probes sets M1 and C1, see Additional File 1, Table S1), (E) following induced expression of mTERF in Flp-In™
T-Rex™-293 cells and (F) in HEK293T cells transfected with mTERF-targeted shRNA versus mock-transfected cells. * denotes statistically
significant differences (t test, p < 0.02). See also Additional File 1, Fig. S3.
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determined the levels of sense-strand transcripts of both
mitochondrial rRNAs relative to cytosolic 18S rRNA
(Fig. 3E, F). Under conditions of induced over-expres-
sion of mTERF, sense-strand transcripts of 12S rRNA
and of 16S rRNA were unchanged relative to each other
and to cytosolic 18S rRNA (Fig. 3E). However, we did
detect a significant increase in sense-strand 12S rRNA
transcripts in cells knocked down for mTERF (Fig. 3F).
Discussion
mTERF and heavy-strand promoter modulation
In this study we investigated the effects of manipulating
the expression level of mTERF on the relative levels of
different mitochondrial transcripts. Under all conditions
tested we failed to detect any significant effects on the
relative levels of mature 16S rRNA and ND1 mRNA
(Fig. 1C, 1D, Additional File 1, S3C). Over-expression of
a tagged mTERF variant, which resulted in the greatest
increase in DNA-binding activity that we were able to
generate (Fig. 5C of [16]), produced no significant
change in the relative levels of the mitochondrial tRNAs
tested, with only a minor decrease in their overall abun-
dance (Fig. 1E). Induced 20-fold over-expression of nat-
ural mTERF in a controlled nuclear background also did
not alter the ratio of mature 16S rRNA to ND1 mRNA,
nor were the levels of 16S or ND1 transcripts affected
relative to transcripts of cytosolic 18S rRNA or 12S
rRNA (Fig. 1C, 3E). Knockdown of mTERF resulted in a
very modest decrease in the level of tRNAPhe relative to
tRNALeu(UUR). However, this was not sufficient to gener-
ate any significant change in the kinetics of recovery of
mitochondrial tRNA levels following EtBr-induced
depletion.
We did, however, obtain two piece of evidence that
mTERF knockdown is not inert as regards transcription
of the mitochondrial heavy strand. Firstly, we observed,
by Northern blots, a small increase in the amount of
mitochondrial tRNAs belonging to each of the heavy-
strand transcription units, relative to cytosolic 5S rRNA
(Fig. 1E) in normal cells after mTERF knockdown. Sec-
ondly, the level of sense-strand 12S rRNA gene tran-
scripts analysed by quantitative RT-PCR was
significantly increased relative to sense-strand 16S rRNA
or cytosolic 18S rRNA gene transcripts (Fig. 3F), in nor-
mal cells knocked down for mTERF. However, the levels
of sense-strand 16S and ND1 transcripts relative to each
other or to 18S were not significantly affected (Fig. 3F).
This suggests the existence of a compensatory mechan-
ism, whereby decreased mTERF levels, which might
otherwise impair 16S rRNA biogenesis, generate a signal
for globally increased mitochondrial transcription (or
decreased turnover) to overcome any such defect. It
may also be noted that the effects of knockdown may be
underestimated due to the rather limited decrease in
mTERF mRNA level that we were able to achieve in
these experiments. A 50% decrease is not untypical in
cultured mammalian cells in cases where knockdown of
a given gene may provoke a growth defect, even just a
transient one, compared with untransfected cells in the
culture. Thus, the effects we observed may likely repre-
sent a combination of normal expression in almost half
the cells, plus greatly reduced expression in the remain-
ing cells.
Nevertheless, our findings imply that the expression
level of mTERF does not determine, in a simple manner,
the relative steady-state levels of transcripts belonging to
the two transcription units of the heavy-stand. Although
mTERF was previously shown to stimulate transcription
in vitro from PH1 in a comparatively crude system
[12,18], it may be noted that no such effect was seen
when purified, recombinant proteins were used [15], or
even in crude extracts using DNA-affinity purified
mTERF [18].
Our results indicate that even if mTERF levels do
influence transcriptional readthrough, a compensatory
response nevertheless adjusts the relative output of dif-
ferent transcripts belonging to the two heavy-strand
transcription units. This may involve the modulation of
transcriptional initiation, post-transcriptional processing
or RNA turnover. Our findings are consistent with pre-
vious reports of the action of thyroid hormone [36] or
variation in ATP supply [37], both of which can influ-
ence the relative rates of transcriptional of initiation at
PH1 and PH2 without any effect on that at the high-
affinity mTERF binding site. It is also possible that
mTERF might have a different physiological function,
and that its effects on transcription are accommodated
by modulating other components of the mitochondrial
RNA synthesis machinery.
Is mTERF activity in HEK293 cells physiological?
All of the current study was conducted in one cell-line
and its derivatives which, as a cancer cell-line, may not
behave in a physiologically normal manner. We consid-
ered the hypothesis that mTERF levels may, in other
cell-types, have a more profound effect on mitochon-
drial transcription but that, in HEK293 cells, mTERF
could be present in such excess that neither over-
expression nor any amount of knockdown achievable by
RNAi technology influences its functional level. How-
ever, from available gene expression data (biogps.gnf.
org) the range of expression of mTERF in different cell-
types in vivo, plus primary tumours and cell-lines
including HEK293 and its derivatives, is only of the
order of 2-5 fold. Furthermore, in HEK293T cells
mTERF is expressed at very close to the median level
for all cells investigated. Therefore, the range of expres-
sion achieved in the present study (~40-fold at the RNA
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level, Fig. 3E, F) far exceeds that known to be experi-
enced in vivo.
Another possibility, given the wealth of previous data
indicating possible post-translational regulation of the
transcriptional activity of mTERF, is that mTERF is con-
stitutively inactivated in HEK293T cells, regardless of its
expression level. Although we analysed DNA-binding
activity as well as RNA levels, some mTERF prepara-
tions that are competent for DNA binding are neverthe-
less unable to influence transcription in vitro [11,24].
This is unlikely, however, since the patterns of mito-
chondrial transcripts in HEK cells, and their responses
to other manipulations, such as increases in the level of
TFAM [38], are similar to other cultured cells and in
vivo tissues.
Thiamphenicol treatment, which alters the representa-
tion of PH1- and PH2-derived transcripts in a manner
similar to thyroid hormone treatment, is able to modify
the EMSA signal at the high-affinity mTERF binding
site, whilst leaving the actual levels of mTERF polypep-
tide unaffected [39]. This may indicate that a post-trans-
lational modification of mTERF could modulate both its
DNA-binding and its transcriptional properties in vivo,
but is equally consistent with the notion that another
factor, capable of binding in this region, is involved.
Final resolution of these issues will require the crea-
tion of an in vivo model in which mTERF levels can be
manipulated over at least as great a range in a tissue-
selective manner. The possibility of redundancy between
mTERF and other members of the mTERF family in
regulating read-through transcription at the 16S/tRNA-
Leu(UUR) gene boundary needs also to be considered.
Modulation of antisense-strand transcripts
We found that alterations in mTERF expression pro-
duced systematic changes in the extent of read-through
transcription in the antisense direction, as inferred from
the relative levels of anti-16S to anti-ND1 transcripts.
Increased levels of mTERF, resulting from stable over-
expression or from induction of Flp-In™ T-Rex™-293
cells transfected with an mTERF expression construct,
shifted the balance of antisense transcripts in the anti-
ND1 direction, whereas mTERF knockdown had the
opposite effect, shifting the balance in favour of anti-
16S. These findings are consistent with the notion that
mTERF, bound to its high affinity binding site in the
tRNALeu(UUR) gene, promotes termination of antisense
transcription initiated at PL, which has traversed most
of circular genome. Increased termination at this site
should deplete the representation of anti-16S, whereas
decreased termination should increase the amount of
anti-16S, consistent with our observations. However, the
effects seen are more complex than implied by this sim-
ple model. Specifically, the shift towards anti-ND1
under conditions of over-expression consists of a rather
drastic decrease in the amount of stable anti-16S, com-
bined with a much smaller decrease in the amount of
anti-ND1 (Fig. 3E). Since there are additional, weaker
binding sites for mTERF in the IQM tRNA cluster and
ND1 coding sequence [16], our finding supports the
idea that a high level of mTERF leads to increased occu-
pancy also of these weaker affinity binding sites,
restraining readthrough into anti-ND1 as well as the
more dramatic effect on readthrough into anti-16S
further downstream. On the other hand, mTERF knock-
down resulted in a clear decrease in the level of anti-
NDI1 but only a small change in anti-16S (Fig. 3F).
These findings imply that maintenance of the physiolo-
gical level of mTERF is important for the formation of
stable antisense transcripts of ND1, by preventing read-
through into the rDNA. If this interpretation is correct,
one in vivo role of mTERF is thus inferred to be the
regulation of antisense transcriptional termination, for
an unknown physiological reason.
In vitro, mTERF exhibits bidirectional termination
activity [15]. If this applies also in vivo, it may be that
the primacy of post-transcriptional processing, the stabi-
lization of rRNA into ribosomal subunits, and compen-
satory effects on transcriptional initiation or RNA
stability, mask or complicate the effects on sense-strand
transcripts. Conversely, antisense transcripts, which are
destined only for turnover (or for some unknown phy-
siological function) would appear to be regulated more
straightforwardly by mTERF.
A somewhat different interpretation arises from the
recent, and thus far unexplained reports of hairpin-loop
transcripts deriving from the 16S rRNA gene, whose
levels appear to reflect the proliferation status and
tumorigenicity of cells [40,41]. It is not yet known how
these transcripts arise. Possibilities are that they are cre-
ated post-transcriptionally by trans-splicing or RNA
ligation, or else that they arise by template strand-
switching during transcription. Our antisense results
could thus imply that mTERF influences the rate of
their production in ways related to or even independent
of its binding to mitochondrial DNA.
Physiological function(s) of mTERF
Given that the effects of mTERF manipulation on the
levels of mature mitochondrial transcripts in vivo appear
to be negated or modified by compensatory mechan-
isms, it may be that the principal physiological function
of this evolutionarily conserved protein is something
other than transcriptional regulation as such. In our pre-
vious study [16] we speculated that mTERF might play
some role in regulating collisions between oppositely
moving transcription and replication machineries, facili-
tating their orderly passage, whilst minimizing the risk
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of stalled replication giving rise to recombinogenic 3’
ends. A requirement for such activity is well established
in both prokaryotic and eukaryotic DNA replication
[42,43], and other members of the mTERF family have
been inferred to play a role in the completion of DNA
replication in human cells [44]. The presence of a tran-
scriptional terminator at a replication pause site more-
over provides a potential primer of lagging-strand
synthesis commencing immediately from the pausing
site, ensuring that no region remains single-stranded
and hence susceptible to DNA damage during pausing.
The RITOLS model of mtDNA replication [45] postu-
lates that the entire lagging strand is laid down initially
as RNA, which might be facilitated by such a mechan-
ism. However, the lagging strand for mtDNA replication
is the same strand as the rRNA. Therefore, if bound
mTERF were to deliver the 3’ end of a paused transcript
to an arriving replication complex, this would be as a
result of its activity in the sense direction. The role of
attenuation on the antisense strand is less clear,
although this might provide a primer required for re-
initiation of the replication machinery at a stalled repli-
cation fork, especially since the former leading strand 3’
end may be unavailable, e.g. due to fork regression. A
role for DnaG primase in replication restart at stalled,
gapped forks has been identified in E. coli [46], serving
as a precedent for primer-dependent restart. Codirec-
tional collisions between the transcription and replica-
tion machineries in E. coli also generate leading-strand
gaps, with the nascent RNA being recruited as a new
primer by the replisome [47].
Another possibility which should be seriously consid-
ered is that mTERF’s effects on nucleic acid metabolism
are incidental to its real biological function inside mito-
chondria, which may be something completely different.
However, arguing against this is the fact that other
members of the mTERF family also affect mitochondrial
transcript levels, including a recently reported case of
the SOLDAT10 protein in Arabidopsis chloroplasts, a
mutation in which appears to activate retrograde signal-
ing by decreasing plastid rRNA synthesis [48]. MOC1,
an mTERF family homologue in Chlamydomonas, is
required for maintaining mitochondrial RNA levels after
exposure to light, although its mechanism of action is
unknown and the broader phenotype of the mutant sug-
gests that the effect might be indirect [49].
Conclusions
In summary, our findings support a role for mTERF in
influencing mitochondrial transcription in vivo, even
though it does not appear to set the levels of mature
mitochondrial transcripts encoded by the PH1 and PH2
heavy-strand transcription units in a simple manner. It
appears to modulate the levels of antisense transcripts,
by implication regulating the extent of readthrough by
the transcriptional machinery of its high-affinity binding
site in the tRNALeu(UUR) gene, as well as other, weaker
mTERF binding sites in the vicinity. Further experi-
ments will now be required to resolve the functional sig-
nificance of this regulation, and its possible relevance to
DNA replication and other processes.
Methods
Cell-lines and cell culture
HEK293T cells and derivatives were cultured in Dulbec-
co’s modified Eagle’s medium (DMEM, Sigma) as pre-
viously [16]. HEK293T-derived cell-clones over-
expressing natural mTERF were created by recloning
the mTERF coding sequence, including its natural stop
codon, into the expression vector pcDNA3.1/hygro(-)
(Invitrogen) as a BamHI/HindIII fragment. Aliquots of
the sequence-verified plasmid DNA (1 μg) were trans-
fected into HEK293T cells using Lipofectamine™ (Invi-
trogen) diluted in 1 ml of Opti-MEM® (Invitrogen)
according to the manufacturer’s protocol. Twenty four
hours later cells were either harvested (for transient
transfection) or placed under hygromycin selection (Cal-
biochem, 200 μg/ml). Hygromycin-resistant colonies
were grown up and tested for expression of the mTERF
transgene by reverse transcriptase (RT)-PCR and by
electrophoretic mobility shift assay (EMSA) as described
in Additional File 1. Flp-In™ T-Rex™ 293 cells trans-
fected with expression constructs for natural mTERF
and for epitope-tagged mTERF-MycHis, as well as their
induction by doxycycline, were as described previously
[16]. mTERF-specific RNA interference was induced by
siRNA for 48 h as described previously [16] or by trans-
fection (using Lipofectamine™ 2000, Invitrogen, manu-
facturer’s protocol) with a customized shRNA construct
(10 μg) targeting the following sequence within mTERF
mRNA (5’ to 3’): GCUGUAACUUGAGUACUUU, Open
Biosystems Expression Arrest™ pSM2 Retroviral shRNA-
mir Library, Oligo ID V2HS_95064 (Thermo Fisher
Scientific, Huntsville, AL, USA). shRNA-transfected cells
were harvested 48 h after transfection.
Depletion of mitochondrial RNA
Cells were passaged one day before adding ethidium
bromide (EtBr) so that the 60 × 15 mm plates were
approximately 50% confluent on the day of experiment.
EtBr was added to the medium to 250 ng/ml and the
cells were incubated for 48 h, after which the plates
were approximately 90% confluent. Cells were then pas-
saged at different densities so that each re-seeded plate
would reach approximately 70-80% confluence when
harvested for RNA extraction. RNA samples were col-
lected before EtBr treatment (day -2), on the day when
drug was washed away (day 0) and 24, 48, 72, 96 and
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120 h after removing EtBr (days 1-5). To ensure com-
plete removal of EtBr the medium was changed 3 h and
6 h after passaging the cells, and then again every day.
Where depletion was carried out in combination with
mTERF-directed RNA interference, siRNA transfection
was carried out prior to the addition of EtBr (day -2)
and was repeated 2 d after removal of the drug (day 2).
RNA extraction, electrophoresis and Northern blotting
Total RNA was extracted from cells using TRIzol®
Reagent (Invitrogen) according to the manufacturer’s
instructions. Any traces of DNA were removed by treat-
ment with RNase-free DNase I (GE Healthcare, manu-
facturer’s recommended conditions), followed by
standard acid phenol/chloroform extraction and isopro-
panol precipitation. For Northern blotting to tRNA
probes RNA samples were electrophoresed at 4°C over-
night at 100 V in neutral 12% acrylamide/7 M urea gels
in TBE buffer, electroblotted onto Zeta-Probe GT mem-
brane (Bio-Rad) at 4°C, u.v.-crosslinked and processed
as described previously [50]. Oligonucleotide probes for
mitochondrial tRNAs and cytosolic 5S rRNA were radi-
olabeled using T4 polynucleotide kinase (PNK, MBI Fer-
mentas) according to the manufacturer’s protocol and
[g-32P] ATP (Amersham Pharmacia Biotech, 3000 Ci/
mmol) and purified using mini Quick Spin Columns
(Roche). The probe oligonucleotide sequences were as
follows (all 5’ to 3’): 5S - GGGTGGTATGGCCGTA-
GAC, tRNALeu(UUR) - GTTTTATGCGATTACCGGGC
and tRNAPhe - CTAAACATTTTCAGTGTATTGC.
Hybridization, washing, autoradiography and phosphori-
maging (Phosphorimager SI, Molecular Dynamics) were
as described previously [51]. For re-probing, the mem-
branes were stripped by boiling in 0.5% SDS solution for
3 min and cooled to room temperature. For Northern
blotting to 16S rRNA or ND1 probes, RNA samples
were fractionated on formaldehyde agarose gels and pro-
cessed for blotting and hybridization as described pre-
viously [51], using probes labelled by random-priming
[50]. The template used for synthesis of the ND1 probe
was as described previously [50]; that for 16S rRNA was
the shorter ApaI digestion product (230 bp) from the
same fragment.
Quantitative RT-PCR
Quantitative RT-PCR was used to estimate the relative
amounts of 12S and16S rRNA, ND1 mRNA, cytosolic
18S rRNA and mTERF mRNA. For cDNA synthesis, 5
μg of RNA was reversed transcribed using 40 units of
M-MuLV reverse transcriptase (Fermentas), primed by
0.2 μg random hexamers (Pharmacia) in a 20 μl reaction
according to manufacturer’s instructions. Three dilu-
tions of each cDNA sample (1:10, 1:20 and 1:50) were
analysed, and each reaction was performed in three
technical replicates. PCR reactions were performed in a
LightCycler™ apparatus using LightCycler FastStart DNA
Master SYBR Green I kit (Roche) according to the man-
ufacturer’s instructions, with the following primer pairs
(all 5’ to 3’) and annealing temperatures: for 18S rRNA,
18Sfor3 - GACGATCAGATACCGTCGTA and 18Srev3
-TGAGGTTTCCCGTGTTGAGT, 52°C; for 16S rRNA,
16Sfor1 - GGTAGAGGCGACAAACCTACCG and
16Srev1 - TTTAGGCCTACTATGGGTGT, 50°C; for
ND1 mRNA, ND1for1 - GGCCAACCTCCTACTCC
and ND1rev1 - GATGGTAGATGTGGCGGGTT, 50°C.
cDNA synthesized from 5 μg of RNA pooled from dif-
ferent cell-lines was used to prepare the standard curve,
based on a five-fold dilution series. The homogeneity of
all products was checked after each run by melting
curve analysis. For strand-specific analysis to distinguish
antisense from sense transcripts, 20 pmol of specific pri-
mer (TIB MOLBIOL, Berlin, Germany, see Additional
File 1, Table S1) were used in the RT step. The PCR
step used custom-designed sets of primers and proxi-
mity-hybridization probes (TIB MOLBIOL, Berlin, Ger-
many, see Additional File 1, Table S1), with LightCycler
(R) FastStart DNA Master HybProbe kit (Roche),
according to manufacturer’s instructions, and annealing
temperatures listed in Additional File 1, Table S1 for
each primer pair. The homogeneity of the products was
checked after each run by melting curve analysis,
according to the annealing temperatures of the hybridi-
zation probes as listed in Additional File 1, Table S1.
Three dilutions (1:10, 1:20 and 1:50) were analysed from
each cDNA. The level of mTERF mRNA relative to 18S
rRNA was measured similarly, using hybridization probe
sets M1 and C1 (see Additional File 1, Table S1), except
that cDNA primed with random hexamers was used as
template.
Additional material
Additional file 1: Supplementary text, Table (S1) and Figures (S1,
S2, S3). All supplementary data is supplied as a single PDF file
containing the following items: Supplementary Methods, Legends to
Supplementary Figures, Supplementary Table (Table S1), Supplementary
Figures S1, S2 and S3.
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